Product Code: MCP-6736
Global Companion Diagnostics Market to Reach $9.2 Billion by 2027
Amid the COVID-19 crisis, the global market for Companion Diagnostics estimated at US$3.4 Billion in the year 2020, is projected to reach a revised size of US$9.2 Billion by 2027, growing at aCAGR of 15.1% over the period 2020-2027. Assay kits & Reagents, one of the segments analyzed in the report, is projected to record 14.3% CAGR and reach US$6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software & Services segment is readjusted to a revised 16.8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1 Billion, While China is Forecast to Grow at 14.6% CAGR
The Companion Diagnostics market in the U.S. is estimated at US$1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 14.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.5% and 13% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 11.1% CAGR.We bring years of research experience to this 18th edition of our report. The 248-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
- Abbott Molecular
- Agilent Technologies, Inc.
- bioMerieux SA
- Cepheid
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Foundation Medicine Inc.
- Laboratory Corporation of America® Holdings
- Leica Biosystems Nussloch GmbH
- Merck & Co. Inc.
- Myriad Genetics Inc.
- NeoGenomics Laboratories, Inc.
- QIAGEN N.V.
- Quest Diagnostics Inc.
- Thermo Fischer Scientific Inc.
TABLE OF CONTENTS
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Impact of Covid-19 and a Looming Global Recession
- Companion Diagnostics: An Introductory Prelude
- Quashing the One-Size-Fits-All Approach, CDx Wield Great Promise for Streamlined Drug Discovery & Development
- Broader Scope and Applications Rev Up Growth Opportunities
- Healthy Growth Projected over the Next Few Years
- Developed Regions: Key Revenue Contributors
- Market Witnesses Fast Paced Growth in Developing Regions
- Northbound Trajectory in R&D Spending Creates Conducive Environment
- Prevailing Economic Scenario Favors Funding Pattern
- Global Competitor Market Shares
- Companion Diagnostics Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Growing Significance of Personalized Medicine Remains a Major Market Driver
- Emphasis on Improving Targeted Therapies with CDx Tests Steers Momentum
- Herceptin Lays the Road for Companion Diagnostics
- Oncology - Dominant Therapy Area for CDx
- Rising Incidence of Cancer Propels the Need for CDx Tests
- Technology Advancements to Widen CDx Use Case
- PCR: Dominant Technology Type for CDx Testing
- Next-Generation Sequencing (NGS) Gains Widespread Traction in CDx Testing
- Significant Role of Biomarkers in Companion Diagnostics
- Critical Healthcare Needs of Aging Population Underpin CDx Sales
- Regulatory Scenario Favors CDx Market
- Resolving Prevailing Challenges: Critical for Future Growth of CDx Market
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: Companion Diagnostics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
- TABLE 2: Companion Diagnostics Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
- TABLE 3: Assay kits & Reagents (Product & Service) World Market by Region/Country in US$ Million: 2020 to 2027
- TABLE 4: Assay kits & Reagents (Product & Service) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
- TABLE 5: Software & Services (Product & Service) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
- TABLE 6: Software & Services (Product & Service) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
- TABLE 7: Polymerase Chain Reaction (PCR) (Technology) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
- TABLE 8: Polymerase Chain Reaction (PCR) (Technology) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
- TABLE 9: Immunohistochemistry (IHC) (Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
- TABLE 10: Immunohistochemistry (IHC) (Technology) Market Share Breakdown by Region/Country: 2020 VS 2027
- TABLE 11: In Situ Hybridization (ISH) (Technology) World Market by Region/Country in US$ Million: 2020 to 2027
- TABLE 12: In Situ Hybridization (ISH) (Technology) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
- TABLE 13: Next-Generation Sequencing (NGS) (Technology) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
- TABLE 14: Next-Generation Sequencing (NGS) (Technology) Market Percentage Share Distribution by Region/Country: 2020 VS 2027
- TABLE 15: Other Technologies (Technology) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027
- TABLE 16: Other Technologies (Technology) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
- TABLE 17: Oncology (Indication) World Market by Region/Country in US$ Million: 2020 to 2027
- TABLE 18: Oncology (Indication) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
- TABLE 19: Neurology (Indication) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
- TABLE 20: Neurology (Indication) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
- TABLE 21: Other Indications (Indication) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
- TABLE 22: Other Indications (Indication) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
- TABLE 23: Pharmaceutical & Biopharmaceutical Companies (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
- TABLE 24: Pharmaceutical & Biopharmaceutical Companies (End-Use) Distribution of Global Sales by Region/Country: 2020 VS 2027
- TABLE 25: Reference Laboratories (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
- TABLE 26: Reference Laboratories (End-Use) Global Market Share Distribution by Region/Country for 2020 and 2027
- TABLE 27: CROs (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
- TABLE 28: CROs (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2020 VS 2027
- TABLE 29: Other End-Uses (End-Use) Worldwide Sales in US$ Million by Region/Country: 2020-2027
- TABLE 30: Other End-Uses (End-Use) Market Share Shift across Key Geographies: 2020 VS 2027
III. MARKET ANALYSIS
- GEOGRAPHIC MARKET ANALYSIS
- UNITED STATES
- Market Facts & Figures
- US Companion Diagnostics Market Share (in %) by Company: 2018 & 2025
- Market Analytics
- TABLE 31: United States Companion Diagnostics Market Estimates and Projections in US$ Million by Product & Service: 2020 to 2027
- TABLE 32: United States Companion Diagnostics Market Share Breakdown by Product & Service: 2020 VS 2027
- TABLE 33: Companion Diagnostics Market in US$ Million in the United States by Technology: 2020-2027
- TABLE 34: United States Companion Diagnostics Market Share Breakdown by Technology: 2020 VS 2027
- TABLE 35: United States Companion Diagnostics Market Estimates and Projections in US$ Million by Indication: 2020 to 2027
- TABLE 36: United States Companion Diagnostics Market Share Breakdown by Indication: 2020 VS 2027
- TABLE 37: United States Companion Diagnostics Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
- TABLE 38: Companion Diagnostics Market Share Breakdown in the United States by End-Use: 2020 VS 2027
- CANADA
- TABLE 39: Canadian Companion Diagnostics Market Estimates and Forecasts in US$ Million by Product & Service: 2020 to 2027
- TABLE 40: Companion Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Product & Service for 2020 and 2027
- TABLE 41: Companion Diagnostics Market Analysis in Canada in US$ Million by Technology: 2020-2027
- TABLE 42: Canadian Companion Diagnostics Market Share Breakdown by Technology: 2020 VS 2027
- TABLE 43: Canadian Companion Diagnostics Market Estimates and Forecasts in US$ Million by Indication: 2020 to 2027
- TABLE 44: Companion Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Indication for 2020 and 2027
- TABLE 45: Canadian Companion Diagnostics Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
- TABLE 46: Canadian Companion Diagnostics Market Share Analysis by End-Use: 2020 VS 2027
- JAPAN
- TABLE 47: Japanese Market for Companion Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product & Service for the Period 2020-2027
- TABLE 48: Japanese Companion Diagnostics Market Share Analysis by Product & Service: 2020 VS 2027
- TABLE 49: Japanese Medium & Long-Term Outlook for Companion Diagnostics Market in US$ Million by Technology: 2020-2027
- TABLE 50: Japanese Companion Diagnostics Market Percentage Share Distribution by Technology: 2020 VS 2027
- TABLE 51: Japanese Market for Companion Diagnostics: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2020-2027
- TABLE 52: Japanese Companion Diagnostics Market Share Analysis by Indication: 2020 VS 2027
- TABLE 53: Japanese Demand Estimates and Forecasts for Companion Diagnostics in US$ Million by End-Use: 2020 to 2027
- TABLE 54: Companion Diagnostics Market Share Shift in Japan by End-Use: 2020 VS 2027
- CHINA
- TABLE 55: Chinese Companion Diagnostics Market Growth Prospects in US$ Million by Product & Service for the Period 2020-2027
- TABLE 56: Chinese Companion Diagnostics Market by Product & Service: Percentage Breakdown of Sales for 2020 and 2027
- TABLE 57: Companion Diagnostics Market Estimates and Forecasts in China in US$ Million by Technology: 2020-2027
- TABLE 58: Companion Diagnostics Market in China: Percentage Share Analysis by Technology for 2020 and 2027
- TABLE 59: Chinese Companion Diagnostics Market Growth Prospects in US$ Million by Indication for the Period 2020-2027
- TABLE 60: Chinese Companion Diagnostics Market by Indication: Percentage Breakdown of Sales for 2020 and 2027
- TABLE 61: Chinese Demand for Companion Diagnostics in US$ Million by End-Use: 2020 to 2027
- TABLE 62: Chinese Companion Diagnostics Market Share Breakdown by End-Use: 2020 VS 2027
- EUROPE
- Market Facts & Figures
- European Companion Diagnostics Market: Competitor Market Share Scenario (in %) for 2018 & 2025
- Market Analytics
- TABLE 63: European Companion Diagnostics Market Demand Scenario in US$ Million by Region/Country: 2018-2025
- TABLE 64: European Companion Diagnostics Market Share Shift by Region/Country: 2020 VS 2027
- TABLE 65: European Companion Diagnostics Market Estimates and Forecasts in US$ Million by Product & Service: 2020-2027
- TABLE 66: European Companion Diagnostics Market Share Breakdown by Product & Service: 2020 VS 2027
- TABLE 67: European Companion Diagnostics Market Assessment in US$ Million by Technology: 2020-2027
- TABLE 68: Companion Diagnostics Market in Europe: Percentage Breakdown of Sales by Technology for 2020 and 2027
- TABLE 69: European Companion Diagnostics Market Estimates and Forecasts in US$ Million by Indication: 2020-2027
- TABLE 70: European Companion Diagnostics Market Share Breakdown by Indication: 2020 VS 2027
- TABLE 71: European Companion Diagnostics Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
- TABLE 72: European Companion Diagnostics Market Share Analysis by End-Use: 2020 VS 2027
- FRANCE
- TABLE 73: Companion Diagnostics Market in France by Product & Service: Estimates and Projections in US$ Million for the Period 2020-2027
- TABLE 74: French Companion Diagnostics Market Share Analysis by Product & Service: 2020 VS 2027
- TABLE 75: French Companion Diagnostics Market Estimates and Projections in US$ Million by Technology: 2020-2027
- TABLE 76: French Companion Diagnostics Market Share Breakdown by Technology: 2020 VS 2027
- TABLE 77: Companion Diagnostics Market in France by Indication: Estimates and Projections in US$ Million for the Period 2020-2027
- TABLE 78: French Companion Diagnostics Market Share Analysis by Indication: 2020 VS 2027
- TABLE 79: Companion Diagnostics Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027
- TABLE 80: French Companion Diagnostics Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
- GERMANY
- TABLE 81: Companion Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product & Service for the Period 2020-2027
- TABLE 82: German Companion Diagnostics Market Share Breakdown by Product & Service: 2020 VS 2027
- TABLE 83: German Companion Diagnostics Latent Demand Forecasts in US$ Million by Technology: 2020-2027
- TABLE 84: German Companion Diagnostics Market Share Breakdown by Technology: 2020 VS 2027
- TABLE 85: Companion Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2020-2027
- TABLE 86: German Companion Diagnostics Market Share Breakdown by Indication: 2020 VS 2027
- TABLE 87: Companion Diagnostics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
- TABLE 88: Companion Diagnostics Market Share Distribution in Germany by End-Use: 2020 VS 2027
- ITALY
- TABLE 89: Italian Companion Diagnostics Market Growth Prospects in US$ Million by Product & Service for the Period 2020-2027
- TABLE 90: Italian Companion Diagnostics Market by Product & Service: Percentage Breakdown of Sales for 2020 and 2027
- TABLE 91: Companion Diagnostics Market Estimates and Forecasts in Italy in US$ Million by Technology: 2020-2027
- TABLE 92: Companion Diagnostics Market in Italy: Percentage Share Analysis by Technology for 2020 and 2027
- TABLE 93: Italian Companion Diagnostics Market Growth Prospects in US$ Million by Indication for the Period 2020-2027
- TABLE 94: Italian Companion Diagnostics Market by Indication: Percentage Breakdown of Sales for 2020 and 2027
- TABLE 95: Italian Demand for Companion Diagnostics in US$ Million by End-Use: 2020 to 2027
- TABLE 96: Italian Companion Diagnostics Market Share Breakdown by End-Use: 2020 VS 2027
- UNITED KINGDOM
- TABLE 97: United Kingdom Market for Companion Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product & Service for the Period 2020-2027
- TABLE 98: United Kingdom Companion Diagnostics Market Share Analysis by Product & Service: 2020 VS 2027
- TABLE 99: United Kingdom Medium & Long-Term Outlook for Companion Diagnostics Market in US$ Million by Technology: 2020-2027
- TABLE 100: United Kingdom Companion Diagnostics Market Percentage Share Distribution by Technology: 2020 VS 2027
- TABLE 101: United Kingdom Market for Companion Diagnostics: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2020-2027
- TABLE 102: United Kingdom Companion Diagnostics Market Share Analysis by Indication: 2020 VS 2027
- TABLE 103: United Kingdom Demand Estimates and Forecasts for Companion Diagnostics in US$ Million by End-Use: 2020 to 2027
- TABLE 104: Companion Diagnostics Market Share Shift in the United Kingdom by End-Use: 2020 VS 2027
- REST OF EUROPE
- TABLE 105: Rest of Europe Companion Diagnostics Market Estimates and Forecasts in US$ Million by Product & Service: 2020-2027
- TABLE 106: Rest of Europe Companion Diagnostics Market Share Breakdown by Product & Service: 2020 VS 2027
- TABLE 107: Rest of Europe Companion Diagnostics Market Assessment in US$ Million by Technology: 2020-2027
- TABLE 108: Companion Diagnostics Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2020 and 2027
- TABLE 109: Rest of Europe Companion Diagnostics Market Estimates and Forecasts in US$ Million by Indication: 2020-2027
- TABLE 110: Rest of Europe Companion Diagnostics Market Share Breakdown by Indication: 2020 VS 2027
- TABLE 111: Rest of Europe Companion Diagnostics Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
- TABLE 112: Rest of Europe Companion Diagnostics Market Share Analysis by End-Use: 2020 VS 2027
- ASIA-PACIFIC
- TABLE 113: Companion Diagnostics Market in Asia-Pacific by Product & Service: Estimates and Projections in US$ Million for the Period 2020-2027
- TABLE 114: Asia-Pacific Companion Diagnostics Market Share Analysis by Product & Service: 2020 VS 2027
- TABLE 115: Asia-Pacific Companion Diagnostics Market Estimates and Projections in US$ Million by Technology: 2020-2027
- TABLE 116: Asia-Pacific Companion Diagnostics Historic Market Analysis in US$ Million by Technology: 2020 VS 2027
- TABLE 117: Companion Diagnostics Market in Asia-Pacific by Indication: Estimates and Projections in US$ Million for the Period 2020-2027
- TABLE 118: Asia-Pacific Companion Diagnostics Market Share Analysis by Indication: 2020 VS 2027
- TABLE 119: Companion Diagnostics Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027
- TABLE 120: Asia-Pacific Companion Diagnostics Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
- REST OF WORLD
- TABLE 121: Rest of World Companion Diagnostics Market Estimates and Forecasts in US$ Million by Product & Service: 2020 to 2027
- TABLE 122: Companion Diagnostics Market in Rest of World: Percentage Share Breakdown of Sales by Product & Service for 2020 and 2027
- TABLE 123: Companion Diagnostics Market Analysis in Rest of World in US$ Million by Technology: 2020-2027
- TABLE 124: Rest of World Companion Diagnostics Market Share Breakdown by Technology: 2020 VS 2027
- TABLE 125: Rest of World Companion Diagnostics Market Estimates and Forecasts in US$ Million by Indication: 2020 to 2027
- TABLE 126: Companion Diagnostics Market in Rest of World: Percentage Share Breakdown of Sales by Indication for 2020 and 2027
- TABLE 127: Rest of World Companion Diagnostics Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
- TABLE 128: Rest of World Companion Diagnostics Market Share Analysis by End-Use: 2020 VS 2027
IV. COMPETITION
- Total Companies Profiled: 80
比較リスト
